Drugmaker Pfizer spent $4.3M lobbying gov't in 1Q

Pfizer Inc., the world's biggest drugmaker, spent $4.3 million lobbying Congress and federal agencies in the first quarter on numerous aspects of the health care overhaul, coverage of its medicines and tax and patent issues, according to a quarterly disclosure report.

Drugmaker Pfizer spent $4.3M lobbying gov't in 1Q